EOLS · Evolus

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

520 Newport Center Drive, Newport Beach, CA, 92660, United States
Drug Manufacturers - Specialty & Generic
Healthcare

Market Cap

510.6M

52 Wk Range

$3.86 - $9.31

Previous Close

$7.80

Open

$7.77

Volume

430,125

Day Range

$7.61 - $7.83

Enterprise Value

648M

Cash

45.17M

Avg Qtr Burn

-3.587M

Insider Ownership

11.25%

Institutional Own.

77.74%

Qtr Updated

Jun 30th 2026